Lightcast Discovery
3 known investors
Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale. The platform serves researchers and therapeutics developers studying functional biology for applications in antibody discovery, cellular therapies, and immunotherapy development.
Investors · 3
In the news
- Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platformbusinesswire.com · 2026
- Lightcast Announces Limited Commercial Release of Envisia™ Single-Cell Functional Analysis Platform for Antibody Discoverybusinesswire.com · 2025
- Empowering research: Lightcast Discovery secures $49M to unveil Single-Cell functional analysis platform — TFNtechfundingnews.com · 2023
- Lightcast Discovery Raises $49M in Series B Financingfinsmes.com · 2023